查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1534099

狐臭治療的全球市場

Bromhidrosis Disease Treatment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 250 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2030年全球狐臭治療市場預計將達到12億美元

2023年全球腋臭治療市場估計為7.563億美元，預計到2030年將達到12億美元，2023-2030年分析期間複合年成長率為6.8%。大汗腺體臭治療是本報告分析的細分市場之一，預計複合年成長率為 7.7%，到分析期結束時將達到 7.428 億美元。在分析期間，小汗腺體臭治療領域的複合年成長率估計為 5.4%。

美國市場預估價值2.06億美元，中國預期複合年成長率11.1%

預計 2023 年美國狐臭治療市場規模將達 2.06 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達2.646億美元，2023年至2030年複合年成長率為11.1%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.9% 和 6.8%。在歐洲，德國的複合年成長率預計為 4.3%。

全球腋臭治療市場－主要促進因素和趨勢總結

臭汗症，俗稱體臭病，是一種以汗液細菌分解引起的過度且令人不快的體臭為特徵的疾病。這種疾病主要影響腋窩和鼠蹊部等區域的頂泌汗腺。狐臭分為大汗腺汗腺病和小汗腺汗腺病。頂泌汗臭汗症與細菌分解汗液有關，而小汗腺臭汗症則與皮膚表面小汗腺分解汗液有關。臭汗症的治療旨在減少汗水分泌、最大限度地減少細菌活動並有效控制氣味。

溴多汗症的治療已經取得了顯著的進展，結合了醫學和非醫學方法。傳統治療方法包括使用含有氯化鋁的局部止汗劑和除臭劑來減少汗水和掩蓋氣味。在更嚴重的情況下，醫生可能會開抗生素來對抗細菌感染，或建議進行抗菌清洗以減少皮膚上的細菌負荷。此外，肉毒桿菌（Botox）注射等治療方法越來越受歡迎，因為它們可以暫時阻斷負責出汗的神經訊號。汗腺切除和切除術等手術選擇為嚴重病例提供了更永久的解決方案。最近的進展還包括雷射療法和微波熱解，它們瞄準並破壞過度活躍的汗腺，從而長期緩解症狀。

溴多汗症治療市場的成長是由多種因素所推動的。首先，與體臭相關的認知的提高和社會恥辱正在促使更多的人尋求治療，從而增加了對有效治療方法的需求。其次，皮膚病學研究和技術的進步擴大了治療選擇，使治療變得更容易和更有效。此外，可支配收入的增加和醫療保健基礎設施的改善，特別是在發展中地區，促進了非侵入性和手術治療的獲得。電子商務和遠端醫療平台的發展也使患者更容易獲得專業治療和諮詢。此外，人口老化更容易出現與出汗相關的問題，這增加了對先進狐臭治療的需求。最後，製藥和化妝品公司為傳播其產品的知名度和益處而進行的策略行銷努力在推動市場擴張方面發揮著重要作用。

受訪企業範例（共86家）

  • Avanor Healthcare Ltd
  • Cantabria Labs
  • Clutch, Inc.（DBA Carpe）
  • Ducray Dermatological Laboratories
  • Galderma SA
  • Ipsen Pharma
  • Medytox, Inc.
  • Merz Pharma
  • No More Sweat
  • Pampered Skin Care, LLC
  • Salve Pharmaceuticals Pvt. Ltd.
  • Seaford Pharmaceuticals Inc.
  • The Polar Company BV

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP26610

Global Bromhidrosis Disease Treatment Market to Reach US$1.2 Billion by 2030

The global market for Bromhidrosis Disease Treatment estimated at US$756.3 Million in the year 2023, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Apocrine Body Odor Treatment, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$742.8 Million by the end of the analysis period. Growth in the Eccrine Body Odor Treatment segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$206.0 Million While China is Forecast to Grow at 11.1% CAGR

The Bromhidrosis Disease Treatment market in the U.S. is estimated at US$206.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$264.6 Million by the year 2030 trailing a CAGR of 11.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Bromhidrosis Disease Treatment Market - Key Drivers and Trends Summarized

Bromhidrosis, commonly known as body odor, is a medical condition characterized by excessive and offensive body odor caused by bacterial decomposition of sweat. This condition primarily affects the apocrine sweat glands found in areas such as the armpits and groin. Bromhidrosis can be classified into two types: apocrine and eccrine. Apocrine bromhidrosis is associated with the bacterial breakdown of sweat, while eccrine bromhidrosis is linked to the decomposition of sweat from the eccrine glands on the skin's surface. Treatment for bromhidrosis aims to reduce sweat production, minimize bacterial activity, and manage the odor effectively.

The treatment landscape for bromhidrosis has evolved considerably, incorporating both medical and non-medical approaches. Traditional treatments include the use of topical antiperspirants and deodorants that contain aluminum chloride to reduce sweat and mask the odor. For more severe cases, physicians may prescribe antibiotics to address bacterial infections or recommend antiseptic washes to reduce bacterial load on the skin. Additionally, treatments such as botulinum toxin (Botox) injections have gained popularity for their ability to temporarily block nerve signals responsible for sweating. Surgical options, including the removal of sweat glands and sympathectomy, offer more permanent solutions for severe cases. Recent advancements also include laser treatments and microwave thermolysis, which target and destroy overactive sweat glands, providing long-term relief from symptoms.

The growth in the bromhidrosis treatment market is driven by several factors. Firstly, the increasing awareness and social stigma associated with body odor have led more individuals to seek medical treatment, boosting demand for effective therapies. Secondly, advancements in dermatological research and technology have expanded treatment options, making them more accessible and efficient. Additionally, the rise in disposable incomes and improved healthcare infrastructure, particularly in developing regions, has facilitated greater access to both non-invasive and surgical treatments. The growth of e-commerce and telemedicine platforms has also made it easier for patients to access specialized treatments and consultations. Furthermore, the aging population, which is more prone to sweat-related issues, has increased the need for advanced bromhidrosis treatments. Lastly, strategic marketing efforts by pharmaceutical and cosmetic companies to promote awareness and the benefits of their products have played a crucial role in driving market expansion.

Select Competitors (Total 86 Featured) -

  • Avanor Healthcare Ltd
  • Cantabria Labs
  • Clutch, Inc. (DBA Carpe)
  • Ducray Dermatological Laboratories
  • Galderma SA
  • Ipsen Pharma
  • Medytox, Inc.
  • Merz Pharma
  • No More Sweat
  • Pampered Skin Care, LLC
  • Salve Pharmaceuticals Pvt. Ltd.
  • Seaford Pharmaceuticals Inc.
  • The Polar Company B.V.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Bromhidrosis Disease Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Bromhidrosis and Its Impact on Quality of Life Drives Demand for Treatments
    • Advancements in Dermatological Treatments Enhance Efficacy and Patient Satisfaction
    • Growing Acceptance of Cosmetic and Aesthetic Procedures Expands Market Opportunities
    • Expansion of Dermatology Clinics and Specialty Centers Increases Market Reach
    • Development of Minimally Invasive and Non-Invasive Treatment Options Attracts Patients
    • Increasing Use of Laser and Radiofrequency Therapies in Bromhidrosis Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Bromhidrosis Disease Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Bromhidrosis Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Apocrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Apocrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Apocrine Body Odor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Eccrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Eccrine Body Odor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Eccrine Body Odor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • JAPAN
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • CHINA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: China 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • EUROPE
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Bromhidrosis Disease Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • FRANCE
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: France 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • GERMANY
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Bromhidrosis Disease Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • INDIA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: India 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Bromhidrosis Disease Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Bromhidrosis Disease Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Bromhidrosis Disease Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030
  • AFRICA
    • Bromhidrosis Disease Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Bromhidrosis Disease Treatment by Type - Apocrine Body Odor and Eccrine Body Odor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Bromhidrosis Disease Treatment by Type - Percentage Breakdown of Value Sales for Apocrine Body Odor and Eccrine Body Odor for the Years 2014, 2024 & 2030

IV. COMPETITION